These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


124 related items for PubMed ID: 167966

  • 1. Evaluation of the cell-mediated immune response to murine sarcoma virus by (125I)iododeoxyuridine assay and comparison with chromium 51 and microcytotoxicity assays.
    Fossati G, Holden HT, Herberman RB.
    Cancer Res; 1975 Sep; 35(9):2600-8. PubMed ID: 167966
    [Abstract] [Full Text] [Related]

  • 2. Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice.
    Herberman RB, Holden HT, Ting CC, Lavrin DL, Kirchner H.
    Cancer Res; 1976 Feb; 36(2 pt 2):615-21. PubMed ID: 56223
    [Abstract] [Full Text] [Related]

  • 3. Secondary cell-mediated cytotoxic response to syngeneic mouse tumor challenge.
    Holden HT, Kirchner H, Herberman RB.
    J Immunol; 1975 Aug; 115(2):327-31. PubMed ID: 168259
    [Abstract] [Full Text] [Related]

  • 4. Comparative in vitro studies on effector cell diversity in the cellular immune response to murine sarcoma virus (MSV)-induced tumors in mice.
    Plata F, Gomard E, Leclerc JC, Levy JP.
    J Immunol; 1974 Apr; 112(4):1477-87. PubMed ID: 4360862
    [No Abstract] [Full Text] [Related]

  • 5. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
    Lamon EW, Whitten HD, Skurzak HM, Andersson B, Lidin B.
    J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777
    [Abstract] [Full Text] [Related]

  • 6. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis.
    Basombrío MA, Mayer AM, Pasqualini CD.
    Cancer Res; 1977 Jun; 37(6):1768-76. PubMed ID: 192461
    [Abstract] [Full Text] [Related]

  • 7. Cell-mediated immunity to Friend virus-induced leukemia. II. Characteristics of primary cell-mediated cytotoxic response.
    Ting CC, Rodgigues D, Bushar GS, Herberman RB.
    J Immunol; 1976 Jan; 116(1):236-43. PubMed ID: 54387
    [Abstract] [Full Text] [Related]

  • 8. Tumor inhibiting capacity of spleen and lymph node cells from mice with murine sarcoma virus (MSV-M)-induced tumors.
    Weiland E, Mussgay M.
    Z Immunitatsforsch Exp Klin Immunol; 1975 Nov; 150(5):414-23. PubMed ID: 181922
    [Abstract] [Full Text] [Related]

  • 9. Cell-mediated immunity to Friend virus-induced leukemia. I. Modification of 125IUdR release cytotoxicity assay for use with suspension target cells.
    Ting C-C, Bushar GS, Rodrigues D, Herberman RB.
    J Immunol; 1975 Nov; 115(5):1351-6. PubMed ID: 170343
    [Abstract] [Full Text] [Related]

  • 10. Significance of the proline assay in the study of anti-MSV cell-mediated immune reactions.
    Henin Y, Gomard E, Gisselbrecht S, Levy JP.
    Br J Cancer; 1979 Jan; 39(1):51-63. PubMed ID: 215185
    [Abstract] [Full Text] [Related]

  • 11. T cell-mediated immunity to oncornavirus-induced tumors. I. Ly phenotype of precursor and effector cytolytic T lymphocytes.
    Leclerc JC, Cantor H.
    J Immunol; 1980 Feb; 124(2):846-50. PubMed ID: 6243332
    [Abstract] [Full Text] [Related]

  • 12. Monoclonal antibody against IFN-gamma inhibits Moloney murine sarcoma virus-specific cytotoxic T lymphocyte differentiation.
    Zanovello P, Vallerani E, Biasi G, Landolfo S, Collavo D.
    J Immunol; 1988 Feb 15; 140(4):1341-4. PubMed ID: 2830339
    [Abstract] [Full Text] [Related]

  • 13. Characterization of effector lymphocytes associated with immunity to murine sarcoma virus (MSV) induced tumors. I. Physical properties of cytolytic T lymphocytes generated in vitro and of their immediate progenitors.
    Plata R, MacDonald HR, Engers HD.
    J Immunol; 1976 Jul 15; 117(1):52-8. PubMed ID: 180182
    [Abstract] [Full Text] [Related]

  • 14. Characterization to effector lymphocytes associated with immunity to murine sarcoma virus (MSV)-induced tumors. II. Repeated stimulation and proliferation in vitro of specific cytolytic T lymphocytes.
    Plata F, Jongeneel CV.
    J Immunol; 1977 Aug 15; 119(2):623-9. PubMed ID: 196025
    [No Abstract] [Full Text] [Related]

  • 15. Antibody production and interaction with lymphoid cells in relation to tumor immunity in the Moloney sarcoma virus system.
    Harada M, Pearson G, Redmon L, Winters E, Kasuga S.
    J Immunol; 1975 Apr 15; 114(4):1318-22. PubMed ID: 1090675
    [Abstract] [Full Text] [Related]

  • 16. Cell-mediated immunity to H-2 antigens. Characteristics of the effector cells as detected in the microcytotoxicity assay.
    Trostmann H, Pfizenmaier K, Wagner H, Röllinghoff M.
    Transplantation; 1976 Jun 15; 21(6):446-53. PubMed ID: 1084606
    [Abstract] [Full Text] [Related]

  • 17. Specific and nonspecific antitumor immunity. I. Description of an in vitro assay based on inhibition of DNA synthesis in tumor cells.
    Williams RM, Germain RN, Benacerraf B.
    J Natl Cancer Inst; 1975 Mar 15; 54(3):697-708. PubMed ID: 1091740
    [Abstract] [Full Text] [Related]

  • 18. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
    Collavo D, Zanovello P, Biasi G, Chieco-Bianchi L.
    J Immunol; 1981 Jan 15; 126(1):187-93. PubMed ID: 6969741
    [Abstract] [Full Text] [Related]

  • 19. Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. I. Model and viral specificity1.
    Wong CY, Woodruff JJ, Woodruff JF.
    J Immunol; 1977 Apr 15; 118(4):1159-64. PubMed ID: 300399
    [Abstract] [Full Text] [Related]

  • 20. Stimulation of mouse migration inhibitory factor (MIF) production form MSV-immune lymphocytes by soluble tumor-associated antigen: requirement for histocompatible macrophages.
    Landolfo S, Herberman RB, Holden HT.
    J Immunol; 1977 Apr 15; 118(4):1244-8. PubMed ID: 191532
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.